| abstract |
The present invention relates to a pharmaceutical agent to suppress the formation of an enzyme, more particularly, to an entirely novel pharmaceutical agent which does not inhibit the action or activity of tyrosinase which has been formed, but prevents its formation. The pharmaceutical agent comprises one or more members selected from the group consisting of acetic acid, lactic acid, pyruvic acid, and their salts and derivatives as the effective component. |